Discovery of Plasmodium vivax N-myristoyltransferase inhibitors - Research Database, The University of York

By the same authors

Site-selective C-C modification of proteins at neutral pH using organocatalyst-mediated cross aldol ligations
Spears, R. J., Brabham, R. L., Budhadev, D., Keenan, T., McKenna, S. E., Walton, J., Brannigan, J. A., Brzozowski, A. M., Wilkinson, A. J., Plevin, M. J. & Fascione, M. A., 7 Jul 2018
Article in Chemical Science
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus
Mousnier, A., Bell, A. S., Swieboda, D. P., Morales-Sanfrutos, J., Pérez-Dorado, I., Brannigan, J. A., Newman, J., Ritzefeld, M., Hutton, J. A., Guedán, A., Asfor, A. S., Robinson, S. W., Hopkins-Navratilova, I., Wilkinson, A. J., Johnston, S. L., Leatherbarrow, R. J., Tuthill, T. J., Solari, R. & Tate, E. W., 1 Jun 2018
Article in Nature Chemistry
Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase
Goncalves, V., Brannigan, J. A., Laporte, A., Bell, A. S., Roberts, S. M., Wilkinson, A. J., Leatherbarrow, R. J. & Tate, E. W., 2017
Article in MedChemComm
N-myristoyltransferase as a Target for Drug Discovery in Malaria
Brannigan, J. A. & Wilkinson, A. J., 2016, Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery. Muller, S., Cerdan, R. & Radulescu, O. (eds.). 1 ed. Weinheim, Germany: Wiley-VCH, Vol. 7. p. 275-294 20 p. 11. (Drug Discovery in Infectious Diseases; vol. 7).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
Structure mediation in substrate binding and post-translational processing of penicillin acylases: Information from mutant structures of Kluyvera citrophila penicillin G acylase
Chand, D., Varshney, N., Ramasamy, S., Panigrahi, P., Brannigan, J. A., Wilkinson, A. J. & Suresh, C. G., 1 Oct 2015
Article in Protein Science

From the same journal

Cell-active Small Molecule Inhibitors of the DNA-damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides
Waszkowycz, B., Smith, K. M., McGonagle, A. E., Jordan, A. M., Acton, B., Fairweather, E. E., Griffiths, L. A., Hamilton, N. M., Hamilton, N. S., Hitchin, J. R., Hutton, C. P., James, D. I., Jones, C. D., Jones, S., Mould, D. P., Small, H. F., Stowell, A. I. J., Tucker, J. A., Waddell, I. D. & Ogilvie, D. J., 13 Dec 2018
Article in JOURNAL OF MEDICINAL CHEMISTRY
Insulin-like Growth Factor 1 Analogs Clicked in the C Domain: Chemical Synthesis and Biological Activities
Macháčková, K., Collinsová, M., Chrudinová, M., Selicharová, I., Pícha, J., Buděšínský, M., Vaněk, V., Žáková, L., Brzozowski, A. M. & Jiráček, J., 28 Dec 2017
Article in JOURNAL OF MEDICINAL CHEMISTRY
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)
Williamson, D. S., Smith, G. P., Acheson-Dossang, P., Bedford, S. T., Chell, V., Chen, I-J., Daechsel, J. C. A., Daniels, Z., David, L., Dokurno, P., Hentzer, M., Herzig, M. C., Hubbard, R. E., Moore, J. D., Murray, J. B., Newland, S., Ray, S. C., Shaw, T., Surgenor, A. E., Terry, L. & 3 others, Thirstrup, K., Wang, Y. & Christensen, K. V., 12 Oct 2017
Article in JOURNAL OF MEDICINAL CHEMISTRY
Structure-based design of potent and selective leishmania N-myristoyltransferase inhibitors
Hutton, J. A., Goncalves, V., Brannigan, J. A., Paape, D., Wright, M. H., Waugh, T. M., Roberts, S. M., Bell, A. S., Wilkinson, A. J., Smith, D. F., Leatherbarrow, R. J. & Tate, E. W., 19 Sep 2014
Article in JOURNAL OF MEDICINAL CHEMISTRY
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP)
Rackham, M. D., Brannigan, J. A., Rangachari, K., Meister, S., Wilkinson, A. J., Holder, A. A., Leatherbarrow, R. J. & Tate, E. W., 27 Mar 2014
Article in JOURNAL OF MEDICINAL CHEMISTRY

Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode

Research output: Contribution to journal › Article

Published copy (DOI)

10.1021/jm300040p

Author(s)

Victor Goncalves
James A Brannigan
David Whalley
Keith H Ansell
Barbara Saxty
Anthony A Holder
Anthony J Wilkinson
Edward W Tate
Robin J Leatherbarrow

Department/unit(s)

Chemistry

Publication details

Journal	JOURNAL OF MEDICINAL CHEMISTRY
Date	Published - 12 Apr 2012
Issue number	7
Volume	55
Number of pages	5
Pages (from-to)	3578-82
Original language	English

Abstract

N-Myristoyltransferase (NMT) is a prospective drug target against parasitic protozoa. Herein we report the successful discovery of a series of Plasmodium vivax NMT inhibitors by high-throughput screening. A high-resolution crystal structure of the hit compound in complex with NMT was obtained, allowing understanding of its novel binding mode. A set of analogues was designed and tested to define the chemical groups relevant for activity and selectivity.

Projects

N-Myristol Transferase as a drug target for anti-malarial therapy
Project: Research project (funded) › Research

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

York staff: edit these data

The York Research Database